Show simple item record

dc.contributor.authorHarris, James
dc.contributor.authorHartman, Michelle L.
dc.contributor.authorRoche, Caitrionna
dc.contributor.authorZeng, Shijuan G.
dc.contributor.authorO'Shea, Amy
dc.contributor.authorSharp, Fiona
dc.contributor.authorLambe, Eimear M.
dc.contributor.authorCreagh, Emma M.
dc.contributor.authorGolenbock, Douglas T.
dc.contributor.authorTschopp, Jurg
dc.contributor.authorKornfeld, Hardy
dc.contributor.authorFitzgerald, Katherine A.
dc.contributor.authorLavelle, Ed C.
dc.date2022-08-11T08:09:08.000
dc.date.accessioned2022-08-23T16:18:43Z
dc.date.available2022-08-23T16:18:43Z
dc.date.issued2011-03-14
dc.date.submitted2011-04-07
dc.identifier.citationJ Biol Chem. 2011 Mar 18;286(11):9587-97. Epub 2011 Jan 12. <a href="http://dx.doi.org/10.1074/jbc.M110.202911">Link to article on publisher's site</a>
dc.identifier.issn0021-9258 Linking
dc.identifier.doi10.1074/jbc.M110.202911
dc.identifier.pmid21228274
dc.identifier.urihttp://hdl.handle.net/20.500.14038/34880
dc.description.abstractAutophagy is a key regulator of cellular homeostasis that can be activated by pathogen-associated molecules and has recently been shown to influence IL-1b secretion by macrophages. However, the mechanisms behind this are unclear. Here, we describe a novel role for autophagy in regulating the production of IL-1b in antigen-presenting cells. After treatment of macrophages with Toll-like receptor (TLR) ligands, pro-IL-1b was specifically sequestered into autophagosomes, while further activation of autophagy with rapamycin induced the degradation of pro-IL-1b and blocked secretion of the mature cytokine. Inhibition of autophagy promoted the processing and secretion of IL-1b by antigen-presenting cells in a NLRP3- and TRIF-dependent manner. This effect was reduced by inhibition of reactive oxygen species (ROS), but was independent of NOX2. Induction of autophagy in mice in vivo with rapamycin reduced serum levels of IL-1b in response to challenge with LPS. These data demonstrate that autophagy controls the production of IL-1b through at least two separate mechanisms; by targeting pro-IL-1 for lysosomal degradation and by regulating activation of the NLRP3 inflammasome.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=21228274&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1074/jbc.M110.202911
dc.subjectAutophagy
dc.subjectInterleukin-1beta
dc.subjectMacrophages
dc.subjectToll-Like Receptors
dc.subjectImmunology and Infectious Disease
dc.titleAutophagy controls IL-1{beta} secretion by targeting pro-IL-1{beta} for degradation
dc.typeJournal Article
dc.source.journaltitleThe Journal of biological chemistry
dc.source.volume286
dc.source.issue11
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/infdis_pp/109
dc.identifier.contextkey1924814
html.description.abstract<p>Autophagy is a key regulator of cellular homeostasis that can be activated by pathogen-associated molecules and has recently been shown to influence IL-1b secretion by macrophages. However, the mechanisms behind this are unclear. Here, we describe a novel role for autophagy in regulating the production of IL-1b in antigen-presenting cells. After treatment of macrophages with Toll-like receptor (TLR) ligands, pro-IL-1b was specifically sequestered into autophagosomes, while further activation of autophagy with rapamycin induced the degradation of pro-IL-1b and blocked secretion of the mature cytokine. Inhibition of autophagy promoted the processing and secretion of IL-1b by antigen-presenting cells in a NLRP3- and TRIF-dependent manner. This effect was reduced by inhibition of reactive oxygen species (ROS), but was independent of NOX2. Induction of autophagy in mice in vivo with rapamycin reduced serum levels of IL-1b in response to challenge with LPS. These data demonstrate that autophagy controls the production of IL-1b through at least two separate mechanisms; by targeting pro-IL-1 for lysosomal degradation and by regulating activation of the NLRP3 inflammasome.</p>
dc.identifier.submissionpathinfdis_pp/109
dc.contributor.departmentDepartment of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine
dc.contributor.departmentDepartment of Medicine, Division of Infectious Diseases and Immunology
dc.source.pages9587-97


This item appears in the following Collection(s)

Show simple item record